Provided by Tiger Trade Technology Pte. Ltd.

Zentalis Pharmaceuticals, LLC

3.11
+0.03000.97%
Post-market: 3.240.1300+4.18%19:50 EDT
Volume:1.26M
Turnover:3.91M
Market Cap:294.43M
PE:-1.59
High:3.18
Open:3.07
Low:2.99
Close:3.08
52wk High:6.95
52wk Low:1.21
Shares:94.67M
Float Shares:75.29M
Volume Ratio:1.20
T/O Rate:1.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9591
EPS(LYR):-1.9100
ROE:-66.75%
ROA:-33.15%
PB:2.05
PE(LYR):-1.63

Loading ...

Morgan Stanley Adjusts PT on Zentalis Pharmaceuticals to $5 From $4, Maintains Equalweight Rating

MT Newswires Live
·
Aug 07

Zentalis Q2 Net Loss Widens on Higher R&D Costs

Reuters
·
Aug 07

Zentalis Pharmaceuticals Q2 EPS USD -0.59

THOMSON REUTERS
·
Aug 07

Zentalis Says Denali Phase 2 Topline Data for Azenosertib Expected in 1H 2027

Reuters
·
Aug 07

Zentalis Grants 84,000 Inducement Stock Options at $4.65 Per Share

Reuters
·
Aug 04

Zentalis Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Aug 04

Zentalis Pharmaceuticals Inc Expected to Post a Loss of 49 Cents a Share - Earnings Preview

Reuters
·
Jul 31

Zentalis Pharmaceuticals Initiated at Buy by Rodman & Renshaw

Dow Jones
·
Jul 24

Zentalis initiated with a Buy at Rodman & Renshaw

TIPRANKS
·
Jul 23

Zentalis grants 191,000 inducement stock options priced at $3.98 per share

Reuters
·
Jun 02

Press Release: Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Dow Jones
·
Jun 02

Zentalis Pharma director Shannon Campbell files initial beneficial ownership statement

Reuters
·
May 28

Zentalis adds Shannon Campbell to board of directors

Reuters
·
May 28

Zentalis Strengthens Commercial Leadership With Appointments of Shannon Campbell to Board of Directors and Sarah Kelly as Svp of Commercial Strategy

THOMSON REUTERS
·
May 28

Zentalis Pharmaceuticals (ZNTL) Receives a Buy from H.C. Wainwright

TIPRANKS
·
May 27

Zentalis reports 39% response rate in Phase 1b ovarian cancer trial combo

Reuters
·
May 22

Zentalis to join H.C. Wainwright BioConnect Conference fireside discussion

Reuters
·
May 14

Wedbush Keeps Their Hold Rating on Zentalis Pharmaceuticals (ZNTL)

TIPRANKS
·
May 13

Oppenheimer Keeps Their Buy Rating on Zentalis Pharmaceuticals (ZNTL)

TIPRANKS
·
May 13

Analysts Conflicted on These Healthcare Names: Omnicell (OMCL), Beam Therapeutics (BEAM) and Zentalis Pharmaceuticals (ZNTL)

TIPRANKS
·
May 13